Klinischer Newsletter

    Klinischer Newsletter

    Für regelmmäßige Updates zu unseren neusten Studien:

    Jetzt Anmelden

    Publikationssuche

    Unsere Forschungs- und Entwicklungsteams sind weltweit im Einsatz und generieren Synergien aus unserem Expertenwissen und verwandten Fachdisziplinen. Wir stehen im internationalen Austausch mit unabhängigen Fachinstitutionen, Key Opinion Leadern und Multiplikatoren, um so Kooperations- und Wissensmanagement auf höchstem Niveau gewährleisten zu können. Im Rahmen dessen führen wir umfangreiche Forschungen durch, die kontinuierlich auf Kongressen in Form von Postern oder freien Vorträgen unserer Kooperationspartner sowie in Symposien und Workshops präsentiert und in namhaften wissenschaftlichen Fachzeitschriften veröffentlicht werden. Die größtenteils von unabhängigen Gutachtern bewerteten, evidenzbasierten Fachpublikationen, stellen wir Ihnen in dieser Datenbank zur Verfügung:

    1. Poster

      Wound debridement with a new debrider: A case report series about dermatologic patients with chronic painful ulcerations of differing aetiology

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria
      Products Debrisoft Pad
    2. Poster

      In vitro model for the evaluation of the effect of dressings used for negative pressure wound therapy (NPWT) on the tissue

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria
      Further languages
    3. Poster

      In-time bedside measurement of the pH value of (chronic) wounds - A new measurement device and first results in chronic wounds

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria
    4. Poster

      CHARACTERISATION OF PATIENTS WITH CHRONIC WOUNDS: HEALTH SERVICES RESEARCH BY ADMINISTRATIVE DATA ANALYSIS

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria
    5. Poster

      In vitro analysis of hemostatic properties and hemocompatibility of collagen and/or ORC-containing wound dressings

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria
      Further versions
    6. Poster

      A MONIFILAMENT DEBRIDEMENT PRODUCT IS IT A NEW SUPPORT FOR DEBRIDEMENT?

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria
      Products Debrisoft Pad
    7. Poster

      A NOVEL TREATMENT METHOD FOR THE REMOVAL OF BIOFLIM MATERIAL

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria
      Products Debrisoft Pad
    8. Poster

      PAIN-FREE WOUND DEBRIDEMENT POSSIBLE? CASE SERIES OF DERMATOLOGY PATIENTS WITH CHRONIC, EXTREMELY PAINFUL ULCERATIONS OF DIFFERENT CAUSES

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria

      Introduction:

      Wound debridement represents a central pillar of the treatment of patients with chronic wounds and is essential in order to be able to carry out further therapeutic measures. Debridement can however often be associated with considerable pain for patients, so that either a radical debridement is not carried out, or analgesia or even surgical intervention with endotracheal anaesthesia are necessary. For patients on whom a particularly adherent fibrinous coating must be removed, a new wound debridement product* made of polyester monofilament fibres represents a new pain-free, therapeutic option.

       

      Material and Methods:

      In our case series, we present five patients from a dermatology wound care clinic with very painful, chronic wounds. The following were diagnosed amongst the patients: one epidermolysis bullosa simplex, one pyoderma gangraenosum, one Martorell’s hypertensive leg ulcer, one leg ulcer in metabolic disease, and one gram-negative infection of the foot. With all patients, it was impossible to carry out surgical debridement under local anaesthetic due to extreme pain. In order to avoid surgical debridement with endotracheal anaesthesia, debridement was carried out on these patients using the new product*.

       

      Results:

      With all patients, it was possible to achieve a virtually complete removal of the fibrinous coating through single use of the debridement product*, heavily humidified with physiological saline solution, without other analgesic measures.

       

      Conclusion:

      Wound debridement using the new debridement product* presents a non-invasive, virtually pain-free alternative, in particular for patients with very painful chronic wounds with pronounced fibrinous coatings. This new treatment option can also be carried out ambulant without the need for considerable material or time.

      Products Debrisoft Pad
    9. Poster

      A SPECIAL CASE: HOW LOWER LIMB AMPUTATION WAS PREVENTED

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria

      Introduction:

      Evaluation of a treatment regime to prevent lower limb amputation in a patient with a venous – arterial - lymphatic leg ulcer. The 66-years-old female patient had an extensive leg ulcer (28.6 cm2) that had been stagnant for three years (Fig.1). She is divorced, lives alone and has two daughters. She has a long history of severe rheumatoid arthritis and is a heavy smoker (25 cigarettes/day). She is somewhat mobile with a walker but spends most of her time in a wheelchair. Her nutritional status is moderate. Patient reported pain was VAS 8.5.

       

      Methods:

      The vascular surgeon has proposed an amputation, but the patient is adamant to keep her leg. She was therefore discharged from the rehabilitation clinic and received her care now in the community. She reports to be angry with the surgeon and is anxious about her future. Although her leg is slim there is edema present (Fig. 3). The wound bed is covered with 95% slough and a small amount of unhealthy looking granulation tissue is present (Fig. 2). Further vascular assessment and biopsies ruled out vasculitis and malignancies (Fig. 4 and Fig. 5).

       

      Results :

      After 8 months the ulcer area had reduced from 28.6 cm2 to 19.1 cm2 (66%) with a healthy looking wound bed. She has stopped smoking, her mobility has improved. The patient is motivated to continue with the treatment and is much more active than at the start of the treatment. She expressed that slowly but gradually she is getting back her life.

       

      Conclusion :

      The multidisciplinary approach provided effective care in the community enabling the patient to improve her condition to spare her leg.

    10. Poster

      CLINICAL EFFICACY OF A MONOFILAMENT FIBER DEBRIDEMENT PRODUCT EVALUATED IN PATIENTS WITH SKIN LESIONS, SCALES, RHAGADES AND HYPERKERATOSIS

      Poster presented at EWMA 2012 23.05.2012 Vienna, Austria
      Products Debrisoft Pad